Emeprid

1 x 10 ml

Liquid for injection, solution

Active substance

Metoclopramide (Metoclopramide hydrochloride) : 5 mg/ml

ATC code

QA03FA01 Metoclopramide

QA03FA Propulsives

QA03F Propulsives

QA03 Drugs for functional gastrointestinal disorders

QA Alimentary tract and metabolism

Species

Dogs and cats.

Indications

Symptomatic treatment of vomiting and reduced gastro-intestinal motility associated with gastritis, pyloric spasm, chronic nephritis and digestive intolerance to some drugs.

Dose to be administered and administration route

Intravenous, intramuscular or subcutaneous use.

0.5 to 1 mg of metoclopramide hydrochloride per kg of body weight per day administered as either:

2.5 to 5.0 mg/10 kg (equivalent to 0.5 to 1 ml/10 kg), twice daily

1.7 to 3.3 mg/10 kg (equivalent to 0.34 to 0.6 ml/10 kg), three times daily.

Injections can be repeated with interval of 6 hours.

Adverse reactions

Dogs:

Rare

(1 to 10 animals / 10,000 animals treated):

Agitation^¹, Aggression^¹, Vocalisation¹

Ataxia¹, Abnormal movement NOS¹, Tremor¹, Prostration,¹

Very rare

(<1 animal / 10,000 animals treated, including isolated reports):

Allergic reaction

¹These observed extrapyramidal effects are transient and disappear when treatment is stopped.

Cats:

Very rare (<1 animal / 10,000 animals treated, including isolated reports):

Agitation¹ , Aggression¹ , Vocalisation¹Ataxia¹ , Abnormal movement NOS¹ , Tremor¹ , Prostration,¹

Allergic reaction

¹These observed extrapyramidal effects are transient and disappear when treatment is stopped.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See also the last section ‘Contact details’ of the package leaflet